lxeo: the income statement

MyFinsight

Lexeo Therapeutics, Inc. (LXEO)

For the quarter ending 2025-06-30, LXEO made $4,658K in revenue. -$26,103K in net income. Net profit margin of -560.39%.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

	2025-06-30
Research and development	14,721
General and administrative	15,967
Total operating expenses	30,688
Operating loss	-30,688
Other income (expense), net	-14
Interest income	1,268
Amortization of premium on investments	34
Interest expense	25
Gain on long-term investment	3,390
Total other income and expense	4,585
Loss from operations before income taxes	-26,103
Net loss	-26,103

Net loss per common share, basic	-0.6
Net loss per common share, diluted	-0.6
Weighted-average common shares outstanding, basic	43,573,628
Weighted-average common shares outstanding, diluted	43,573,628

Unit: Thousand (K) dollars (except for numbers of shares and EPS)